Abstract
Filtration Industry AnalystVol. 2021, No. 11 Donaldson expands in life sciences with Solaris Biotechnology acquisitionPublished Online:11 Dec 2021AboutSectionsView articleView Full TextPDF/EPUB ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareShare onFacebookTwitterLinked InEmail View articleAbstractDonaldson Co Inc has acquired Solaris Biotechnology Srl, an Italian designer and manufacturer of bioprocessing equipment, including bioreactors, fermenters and tangential flow filtration systems, in a €41 million deal. FiguresReferencesRelatedDetails 1 January 2021Volume 2021Issue 11ISSN (print): 1365-6937ISSN (online): 1873-6440 Metrics History Published online 11 December 2021 Published in print 1 January 2021 Information© MA Business Ltd.PDF download
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
